查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
戒煙與去尼古丁中毒市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1121629

戒煙與去尼古丁中毒市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Smoking Cessation and Nicotine De-Addiction Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 375 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球戒煙和去尼古丁中毒市場相關調查，市場概要，以及2022年～2031年的預測，各產品類型，各流通管道，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 假設

第3章 調查手法

第4章 摘要整理

第5章 市場概要

  • 市場動態
  • 主要趨勢分析
  • 主要的市場指標
  • 波特的五力分析
  • 價值鏈分析
  • 產業的SWOT分析
  • 全球戒煙和去尼古丁中毒的市場分析，2017年～2031年

第6章 全球戒煙和去尼古丁中毒市場分析與預測，各產品類型

  • 全球戒煙和去尼古丁中毒市場規模(100萬美元)，各產品類型，2017年～2031年
    • 商品(尼古丁)
    • 產品(無尼古丁)
  • 各產品類型機會

第7章 全球戒煙和去尼古丁中毒市場分析與預測，各流通管道

  • 全球戒煙和去尼古丁中毒市場規模(100萬美元)，各流通管道，2017年～2031年
    • 線上
    • 離線
  • 各流通管道機會

第8章 全球戒煙和去尼古丁中毒市場分析與預測，各地區

  • 全球戒煙和去尼古丁中毒市場規模(100萬美元)，各地區，2017年～2031年
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美
  • 各地區機會

第9章 北美的戒煙和去尼古丁中毒市場分析與預測

第10章 歐洲的戒煙和去尼古丁中毒市場分析與預測

第11章 亞太地區的戒煙和去尼古丁中毒市場分析與預測

第12章 中東、非洲的戒煙和去尼古丁中毒市場分析與預測

第13章 南美的戒煙和去尼古丁中毒市場分析與預測

第14章 競爭情形

  • 市場參與企業-競爭儀表板
  • 企業簡介
    • Pfizer Inc.
    • GlaxoSmithKline plc(GSK)
    • Cipla Ltd.
    • Johnson &Johnson(J&J)
    • ITC Ltd.
    • Takeda Pharmaceutical Company Ltd
    • Alkalon A/S
    • 22nd Century Group, Inc.
    • Strides Pharma Science Ltd
    • JUUL Labs, Inc.

第15章 重要點

Product Code: TMRGL1849

The report provides revenue of the global smoking cessation and nicotine de-addiction market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global smoking cessation and nicotine de-addiction market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the smoking cessation and nicotine de-addiction market.

The report delves into the competitive landscape of the global smoking cessation and nicotine de-addiction market. Key players operating in the global smoking cessation and nicotine de-addiction market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global smoking cessation and nicotine de-addiction market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions

3. Research Methodology

4. Executive Summary

5. Market Overview

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunities
  • 5.2. Key Trends Analysis
    • 5.2.1. Demand Side Analysis
    • 5.2.2. Supply Side Analysis
  • 5.3. Key Market Indicators
  • 5.4. Porter's Five Forces Analysis
  • 5.5. Value Chain Analysis
  • 5.6. Industry SWOT Analysis
  • 5.7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, 2017-2031
    • 5.7.1. Market Value Projections (US$ Mn)

6. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Product Type

  • 6.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 6.1.1. Product (with nicotine)
      • 6.1.1.1. OTC Products
        • 6.1.1.1.1. E-cigarettes
        • 6.1.1.1.2. Nicotine Gums (NRT)
        • 6.1.1.1.3. Nicotine Patches (NRT)
        • 6.1.1.1.4. Nicotine Lozenges (NRT)
        • 6.1.1.1.5. Nicotine Tablets (NRT)
      • 6.1.1.2. Prescription Products
        • 6.1.1.2.1. Nicotine Sprays (NRT)
        • 6.1.1.2.2. Nicotine Inhalers (NRT)
    • 6.1.2. Product (without nicotine)
      • 6.1.2.1. Prescription Products
        • 6.1.2.1.1. Zyban
        • 6.1.2.1.2. Chantix
  • 6.2. Incremental Opportunity, by Product Type

7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Distribution Channel

  • 7.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn)t, By Distribution Channel, 2017-2031
    • 7.1.1. Online
    • 7.1.2. Offline
  • 7.2. Incremental Opportunity, by Distribution Channel

8. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, Region

  • 8.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Region, 2017-2031
    • 8.1.1. North America
    • 8.1.2. Europe
    • 8.1.3. Asia Pacific
    • 8.1.4. Middle East & Africa
    • 8.1.5. South America
  • 8.2. Incremental Opportunity, by Region

9. North America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 9.1. Regional Snapshot
  • 9.2. Price Trend Analysis
    • 9.2.1. Weighted Average Selling Price (US$)
  • 9.3. Key Trends Analysis
    • 9.3.1. Demand Side Analysis
    • 9.3.2. Supply Side Analysis
  • 9.4. COVID-19 Impact Analysis
  • 9.5. Key Supplier Analysis
  • 9.6. Consumer Buying Behavior Analysis
  • 9.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 9.7.1. Product (with nicotine)
      • 9.7.1.1. OTC Products
        • 9.7.1.1.1. E-cigarettes
        • 9.7.1.1.2. Nicotine Gums (NRT)
        • 9.7.1.1.3. Nicotine Patches (NRT)
        • 9.7.1.1.4. Nicotine Lozenges (NRT)
        • 9.7.1.1.5. Nicotine Tablets (NRT)
      • 9.7.1.2. Prescription Products
        • 9.7.1.2.1. Nicotine Sprays (NRT)
        • 9.7.1.2.2. Nicotine Inhalers (NRT)
    • 9.7.2. Product (without nicotine)
      • 9.7.2.1. Prescription Products
        • 9.7.2.1.1. Zyban
        • 9.7.2.1.2. Chantix
  • 9.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 9.8.1. Online
    • 9.8.2. Offline
  • 9.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 9.9.1. U.S.
    • 9.9.2. Canada
    • 9.9.3. Rest of North America
  • 9.10. Incremental Opportunity Analysis

10. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 10.1. Regional Snapshot
  • 10.2. Price Trend Analysis
    • 10.2.1. Weighted Average Selling Price (US$)
  • 10.3. Key Trends Analysis
    • 10.3.1. Demand Side Analysis
    • 10.3.2. Supply Side Analysis
  • 10.4. COVID-19 Impact Analysis
  • 10.5. Key Supplier Analysis
  • 10.6. Consumer Buying Behavior Analysis
  • 10.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 10.7.1. Product (with nicotine)
      • 10.7.1.1. OTC Products
        • 10.7.1.1.1. E-cigarettes
        • 10.7.1.1.2. Nicotine Gums (NRT)
        • 10.7.1.1.3. Nicotine Patches (NRT)
        • 10.7.1.1.4. Nicotine Lozenges (NRT)
        • 10.7.1.1.5. Nicotine Tablets (NRT)
      • 10.7.1.2. Prescription Products
        • 10.7.1.2.1. Nicotine Sprays (NRT)
        • 10.7.1.2.2. Nicotine Inhalers (NRT)
    • 10.7.2. Product (without nicotine)
      • 10.7.2.1. Prescription Products
        • 10.7.2.1.1. Zyban
        • 10.7.2.1.2. Chantix
  • 10.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
    • 10.8.1. Online
    • 10.8.2. Offline
  • 10.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 10.9.1. U.K.
    • 10.9.2. Germany
    • 10.9.3. France
    • 10.9.4. Rest of Europe
  • 10.10. Incremental Opportunity Analysis

11. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 11.1. Regional Snapshot
  • 11.2. Price Trend Analysis
    • 11.2.1. Weighted Average Selling Price (US$)
  • 11.3. Key Trends Analysis
    • 11.3.1. Demand Side Analysis
    • 11.3.2. Supply Side Analysis
  • 11.4. COVID-19 Impact Analysis
  • 11.5. Key Supplier Analysis
  • 11.6. Consumer Buying Behavior Analysis
  • 11.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 11.7.1. Product (with nicotine)
      • 11.7.1.1. OTC Products
        • 11.7.1.1.1. E-cigarettes
        • 11.7.1.1.2. Nicotine Gums (NRT)
        • 11.7.1.1.3. Nicotine Patches (NRT)
        • 11.7.1.1.4. Nicotine Lozenges (NRT)
        • 11.7.1.1.5. Nicotine Tablets (NRT)
      • 11.7.1.2. Prescription Products
        • 11.7.1.2.1. Nicotine Sprays (NRT)
        • 11.7.1.2.2. Nicotine Inhalers (NRT)
    • 11.7.2. Product (without nicotine)
      • 11.7.2.1. Prescription Products
        • 11.7.2.1.1. Zyban
        • 11.7.2.1.2. Chantix
  • 11.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 11.8.1. Online
    • 11.8.2. Offline
  • 11.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 11.9.1. China
    • 11.9.2. India
    • 11.9.3. Japan
    • 11.9.4. Rest of Asia Pacific
  • 11.10. Incremental Opportunity Analysis

12. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 12.1. Regional Snapshot
  • 12.2. Price Trend Analysis
    • 12.2.1. Weighted Average Selling Price (US$)
  • 12.3. Key Trends Analysis
    • 12.3.1. Demand Side Analysis
    • 12.3.2. Supply Side Analysis
  • 12.4. COVID-19 Impact Analysis
  • 12.5. Key Supplier Analysis
  • 12.6. Consumer Buying Behavior Analysis
  • 12.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 12.7.1. Product (with nicotine)
      • 12.7.1.1. OTC Products
        • 12.7.1.1.1. E-cigarettes
        • 12.7.1.1.2. Nicotine Gums (NRT)
        • 12.7.1.1.3. Nicotine Patches (NRT)
        • 12.7.1.1.4. Nicotine Lozenges (NRT)
        • 12.7.1.1.5. Nicotine Tablets (NRT)
      • 12.7.1.2. Prescription Products
        • 12.7.1.2.1. Nicotine Sprays (NRT)
        • 12.7.1.2.2. Nicotine Inhalers (NRT)
    • 12.7.2. Product (without nicotine)
      • 12.7.2.1. Prescription Products
        • 12.7.2.1.1. Zyban
        • 12.7.2.1.2. Chantix
  • 12.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 12.8.1. Online
    • 12.8.2. Offline
  • 12.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 12.9.1. GCC
    • 12.9.2. South Africa
    • 12.9.3. Rest of Middle East & Africa
  • 12.10. Incremental Opportunity Analysis

13. South America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 13.1. Regional Snapshot
  • 13.2. Price Trend Analysis
    • 13.2.1. Weighted Average Selling Price (US$)
  • 13.3. Key Trends Analysis
    • 13.3.1. Demand Side Analysis
    • 13.3.2. Supply Side Analysis
  • 13.4. COVID-19 Impact Analysis
  • 13.5. Key Supplier Analysis
  • 13.6. Consumer Buying Behavior Analysis
  • 13.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 13.7.1. Product (with nicotine)
      • 13.7.1.1. OTC Products
        • 13.7.1.1.1. E-cigarettes
        • 13.7.1.1.2. Nicotine Gums (NRT)
        • 13.7.1.1.3. Nicotine Patches (NRT)
        • 13.7.1.1.4. Nicotine Lozenges (NRT)
        • 13.7.1.1.5. Nicotine Tablets (NRT)
      • 13.7.1.2. Prescription Products
        • 13.7.1.2.1. Nicotine Sprays (NRT)
        • 13.7.1.2.2. Nicotine Inhalers (NRT)
    • 13.7.2. Product (without nicotine)
      • 13.7.2.1. Prescription Products
        • 13.7.2.1.1. Zyban
        • 13.7.2.1.2. Chantix
  • 13.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 13.8.1. Online
    • 13.8.2. Offline
  • 13.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 13.9.1. Brazil
    • 13.9.2. Rest of South America
  • 13.10. Incremental Opportunity Analysis

14. Competition Landscape

  • 14.1. Market Player - Competition Dashboard
  • 14.2. Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Financial/Revenue, Strategy & Business Overview, Sales Channel Analysis, Size Portfolio)
    • 14.2.1. Pfizer Inc.
      • 14.2.1.1. Company Overview
      • 14.2.1.2. Sales Area/Geographical Presence
      • 14.2.1.3. Financial/Revenue
      • 14.2.1.4. Strategy & Business Overview
      • 14.2.1.5. Sales Channel Analysis
      • 14.2.1.6. Size Portfolio
    • 14.2.2. GlaxoSmithKline plc (GSK)
      • 14.2.2.1. Company Overview
      • 14.2.2.2. Sales Area/Geographical Presence
      • 14.2.2.3. Financial/Revenue
      • 14.2.2.4. Strategy & Business Overview
      • 14.2.2.5. Sales Channel Analysis
      • 14.2.2.6. Size Portfolio
    • 14.2.3. Cipla Ltd.
      • 14.2.3.1. Company Overview
      • 14.2.3.2. Sales Area/Geographical Presence
      • 14.2.3.3. Financial/Revenue
      • 14.2.3.4. Strategy & Business Overview
      • 14.2.3.5. Sales Channel Analysis
      • 14.2.3.6. Size Portfolio
    • 14.2.4. Johnson & Johnson (J&J)
      • 14.2.4.1. Company Overview
      • 14.2.4.2. Sales Area/Geographical Presence
      • 14.2.4.3. Financial/Revenue
      • 14.2.4.4. Strategy & Business Overview
      • 14.2.4.5. Sales Channel Analysis
      • 14.2.4.6. Size Portfolio
    • 14.2.5. ITC Ltd.
      • 14.2.5.1. Company Overview
      • 14.2.5.2. Sales Area/Geographical Presence
      • 14.2.5.3. Financial/Revenue
      • 14.2.5.4. Strategy & Business Overview
      • 14.2.5.5. Sales Channel Analysis
      • 14.2.5.6. Size Portfolio
    • 14.2.6. Takeda Pharmaceutical Company Ltd
      • 14.2.6.1. Company Overview
      • 14.2.6.2. Sales Area/Geographical Presence
      • 14.2.6.3. Financial/Revenue
      • 14.2.6.4. Strategy & Business Overview
      • 14.2.6.5. Sales Channel Analysis
      • 14.2.6.6. Size Portfolio
    • 14.2.7. Alkalon A/S
      • 14.2.7.1. Company Overview
      • 14.2.7.2. Sales Area/Geographical Presence
      • 14.2.7.3. Financial/Revenue
      • 14.2.7.4. Strategy & Business Overview
      • 14.2.7.5. Sales Channel Analysis
      • 14.2.7.6. Size Portfolio
    • 14.2.8. 22nd Century Group, Inc.
      • 14.2.8.1. Company Overview
      • 14.2.8.2. Sales Area/Geographical Presence
      • 14.2.8.3. Financial/Revenue
      • 14.2.8.4. Strategy & Business Overview
      • 14.2.8.5. Sales Channel Analysis
      • 14.2.8.6. Size Portfolio
    • 14.2.9. Strides Pharma Science Ltd
      • 14.2.9.1. Company Overview
      • 14.2.9.2. Sales Area/Geographical Presence
      • 14.2.9.3. Financial/Revenue
      • 14.2.9.4. Strategy & Business Overview
      • 14.2.9.5. Sales Channel Analysis
      • 14.2.9.6. Size Portfolio
    • 14.2.10. JUUL Labs, Inc.
      • 14.2.10.1. Company Overview
      • 14.2.10.2. Sales Area/Geographical Presence
      • 14.2.10.3. Financial/Revenue
      • 14.2.10.4. Strategy & Business Overview
      • 14.2.10.5. Sales Channel Analysis
      • 14.2.10.6. Size Portfolio

15. Key Takeaway

List of Tables

  • Table 1: Global Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 2: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 3: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Region, US$ Mn, 2017-2031
  • Table 4: North America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 5: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 6: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 7: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 8: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 9: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 10: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 11: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 12: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 15: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 16: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 17: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 18: South America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 19: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 20: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031

List of Figures

  • Figure 1: Global Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 2: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 3: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 4: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 5: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Region, US$ Mn, 2017-2031
  • Figure 6: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Region,2022-2031
  • Figure 7: North America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 8: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 9: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 10: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2021-2031
  • Figure 11: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 12: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 13: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 14: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 15: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 16: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 17: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 18: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 19: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 20: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 21: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 22: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 23: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 24: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 25: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 26: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Product Type, 2022-2031
  • Figure 27: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 28: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 29: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 30: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 31: South America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 32: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 33: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 34: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 35: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 36: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031